Medtronic (MDT) news

Medtronic PLC: TD Cowen raises target price to $110 from $100

TD Cowen has revised its price target for Medtronic PLC (MDT) to $110 from $100, reflecting a more optimistic outlook . The adjustment follows recent developments in Medtronic’s business performance and market positioning. Analysts have noted the company’s strong fundamentals, including its…

Medtronic PLC: Needham raises target price to $114 from 101

Mubadala Investment Co PJSC dissolves share stake in Medtronic PLC - SEC filing

Mubadala Investment Co PJSC has reported a change in its shareholding position in Medtronic PLC, according to a recent SEC filing. The filing indicates that the Abu Dhabi-based investment company has reduced its stake in the medical technology firm, which marks previously disclosed holdings as of…

Leerink Partners raises to outperform from market perform; raises target price to $110 from $83

Leerink Partners has upgraded its rating on Boston Scientific (NYSE:BSX) to Outperform from Market Perform, while raising its price target to $118 from $83. The firm cited several company-specific catalysts and improving fundamentals as key drivers for the upgrade. Notably, Leerink highlighted…

US jury says Medtronic owes $88 million in first case to go to trial over Covidien's hernia mesh - attorney

A U.S. federal jury has ruled that Medtronic (MDT.N) is liable for $88 million in the first trial of thousands of lawsuits related to hernia mesh products manufactured by its subsidiary, Covidien. The case, Patterson v. Covidien Inc, centered on claims that a defective Symbotex mesh implant caused…